世界のヘモグロビン症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Hemoglobinopathy Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5774
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、ヘモグロビン症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヒドロキシウレア、グルタミン、ジンテグロ、その他）、用途別市場規模（鎌状赤血球症、サラセミア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・ヘモグロビン症治療の市場動向
・企業の競争状況、市場シェア
・ヘモグロビン症治療の種類別市場規模と予測2016-2027（ヒドロキシウレア、グルタミン、ジンテグロ、その他）
・ヘモグロビン症治療の用途別市場規模と予測2016-2027（鎌状赤血球症、サラセミア）
・ヘモグロビン症治療の北米市場規模2016-2027（アメリカ、カナダ）
・ヘモグロビン症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・ヘモグロビン症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・ヘモグロビン症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・ヘモグロビン症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Novartis、AstraZeneca、Bluebird、Bristol-Myers Squibb、Emmaus Medical、Acceleron Pharma、HemaQuest Pharmaceuticals、Eli Lilly and Company、Celgene）
・結論

Hemoglobinopathy includes a range of disorders, which occur due to altered structure of hemoglobin.

Market Analysis and Insights: Global Hemoglobinopathy Treatment Market
The global Hemoglobinopathy Treatment market size is projected to reach US$ 384.7 million by 2027, from US$ 274.5 million in 2020, at a CAGR of 4.5% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hemoglobinopathy Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hemoglobinopathy Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hemoglobinopathy Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hemoglobinopathy Treatment market.

Global Hemoglobinopathy Treatment Scope and Market Size
Hemoglobinopathy Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hemoglobinopathy Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Hydroxyurea
Glutamine
Zynteglo
Other

Segment by Application
Sickle Cell Diseases
Thalassemia

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis
AstraZeneca
Bluebird
Bristol-Myers Squibb
Emmaus Medical
Acceleron Pharma
HemaQuest Pharmaceuticals
Eli Lilly and Company
Celgene

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hemoglobinopathy Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hydroxyurea
1.2.3 Glutamine
1.2.4 Zynteglo
1.2.5 Other
1.3 Market by Application
1.3.1 Global Hemoglobinopathy Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Sickle Cell Diseases
1.3.3 Thalassemia
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hemoglobinopathy Treatment Market Perspective (2016-2027)
2.2 Hemoglobinopathy Treatment Growth Trends by Regions
2.2.1 Hemoglobinopathy Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hemoglobinopathy Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Hemoglobinopathy Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Hemoglobinopathy Treatment Industry Dynamic
2.3.1 Hemoglobinopathy Treatment Market Trends
2.3.2 Hemoglobinopathy Treatment Market Drivers
2.3.3 Hemoglobinopathy Treatment Market Challenges
2.3.4 Hemoglobinopathy Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hemoglobinopathy Treatment Players by Revenue
3.1.1 Global Top Hemoglobinopathy Treatment Players by Revenue (2016-2021)
3.1.2 Global Hemoglobinopathy Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Hemoglobinopathy Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hemoglobinopathy Treatment Revenue
3.4 Global Hemoglobinopathy Treatment Market Concentration Ratio
3.4.1 Global Hemoglobinopathy Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hemoglobinopathy Treatment Revenue in 2020
3.5 Hemoglobinopathy Treatment Key Players Head office and Area Served
3.6 Key Players Hemoglobinopathy Treatment Product Solution and Service
3.7 Date of Enter into Hemoglobinopathy Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hemoglobinopathy Treatment Breakdown Data by Type
4.1 Global Hemoglobinopathy Treatment Historic Market Size by Type (2016-2021)
4.2 Global Hemoglobinopathy Treatment Forecasted Market Size by Type (2022-2027)

5 Hemoglobinopathy Treatment Breakdown Data by Application
5.1 Global Hemoglobinopathy Treatment Historic Market Size by Application (2016-2021)
5.2 Global Hemoglobinopathy Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hemoglobinopathy Treatment Market Size (2016-2027)
6.2 North America Hemoglobinopathy Treatment Market Size by Type
6.2.1 North America Hemoglobinopathy Treatment Market Size by Type (2016-2021)
6.2.2 North America Hemoglobinopathy Treatment Market Size by Type (2022-2027)
6.2.3 North America Hemoglobinopathy Treatment Market Size by Type (2016-2027)
6.3 North America Hemoglobinopathy Treatment Market Size by Application
6.3.1 North America Hemoglobinopathy Treatment Market Size by Application (2016-2021)
6.3.2 North America Hemoglobinopathy Treatment Market Size by Application (2022-2027)
6.3.3 North America Hemoglobinopathy Treatment Market Size by Application (2016-2027)
6.4 North America Hemoglobinopathy Treatment Market Size by Country
6.4.1 North America Hemoglobinopathy Treatment Market Size by Country (2016-2021)
6.4.2 North America Hemoglobinopathy Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Hemoglobinopathy Treatment Market Size (2016-2027)
7.2 Europe Hemoglobinopathy Treatment Market Size by Type
7.2.1 Europe Hemoglobinopathy Treatment Market Size by Type (2016-2021)
7.2.2 Europe Hemoglobinopathy Treatment Market Size by Type (2022-2027)
7.2.3 Europe Hemoglobinopathy Treatment Market Size by Type (2016-2027)
7.3 Europe Hemoglobinopathy Treatment Market Size by Application
7.3.1 Europe Hemoglobinopathy Treatment Market Size by Application (2016-2021)
7.3.2 Europe Hemoglobinopathy Treatment Market Size by Application (2022-2027)
7.3.3 Europe Hemoglobinopathy Treatment Market Size by Application (2016-2027)
7.4 Europe Hemoglobinopathy Treatment Market Size by Country
7.4.1 Europe Hemoglobinopathy Treatment Market Size by Country (2016-2021)
7.4.2 Europe Hemoglobinopathy Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hemoglobinopathy Treatment Market Size (2016-2027)
8.2 Asia-Pacific Hemoglobinopathy Treatment Market Size by Type
8.2.1 Asia-Pacific Hemoglobinopathy Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hemoglobinopathy Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hemoglobinopathy Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Hemoglobinopathy Treatment Market Size by Application
8.3.1 Asia-Pacific Hemoglobinopathy Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hemoglobinopathy Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hemoglobinopathy Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Hemoglobinopathy Treatment Market Size by Region
8.4.1 Asia-Pacific Hemoglobinopathy Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hemoglobinopathy Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hemoglobinopathy Treatment Market Size (2016-2027)
9.2 Latin America Hemoglobinopathy Treatment Market Size by Type
9.2.1 Latin America Hemoglobinopathy Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Hemoglobinopathy Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Hemoglobinopathy Treatment Market Size by Type (2016-2027)
9.3 Latin America Hemoglobinopathy Treatment Market Size by Application
9.3.1 Latin America Hemoglobinopathy Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Hemoglobinopathy Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Hemoglobinopathy Treatment Market Size by Application (2016-2027)
9.4 Latin America Hemoglobinopathy Treatment Market Size by Country
9.4.1 Latin America Hemoglobinopathy Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Hemoglobinopathy Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hemoglobinopathy Treatment Market Size (2016-2027)
10.2 Middle East & Africa Hemoglobinopathy Treatment Market Size by Type
10.2.1 Middle East & Africa Hemoglobinopathy Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hemoglobinopathy Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hemoglobinopathy Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Hemoglobinopathy Treatment Market Size by Application
10.3.1 Middle East & Africa Hemoglobinopathy Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hemoglobinopathy Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hemoglobinopathy Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Hemoglobinopathy Treatment Market Size by Country
10.4.1 Middle East & Africa Hemoglobinopathy Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hemoglobinopathy Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Hemoglobinopathy Treatment Introduction
11.1.4 Novartis Revenue in Hemoglobinopathy Treatment Business (2016-2021)
11.1.5 Novartis Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Hemoglobinopathy Treatment Introduction
11.2.4 AstraZeneca Revenue in Hemoglobinopathy Treatment Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Bluebird
11.3.1 Bluebird Company Details
11.3.2 Bluebird Business Overview
11.3.3 Bluebird Hemoglobinopathy Treatment Introduction
11.3.4 Bluebird Revenue in Hemoglobinopathy Treatment Business (2016-2021)
11.3.5 Bluebird Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Hemoglobinopathy Treatment Introduction
11.4.4 Bristol-Myers Squibb Revenue in Hemoglobinopathy Treatment Business (2016-2021)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Emmaus Medical
11.5.1 Emmaus Medical Company Details
11.5.2 Emmaus Medical Business Overview
11.5.3 Emmaus Medical Hemoglobinopathy Treatment Introduction
11.5.4 Emmaus Medical Revenue in Hemoglobinopathy Treatment Business (2016-2021)
11.5.5 Emmaus Medical Recent Development
11.6 Acceleron Pharma
11.6.1 Acceleron Pharma Company Details
11.6.2 Acceleron Pharma Business Overview
11.6.3 Acceleron Pharma Hemoglobinopathy Treatment Introduction
11.6.4 Acceleron Pharma Revenue in Hemoglobinopathy Treatment Business (2016-2021)
11.6.5 Acceleron Pharma Recent Development
11.7 HemaQuest Pharmaceuticals
11.7.1 HemaQuest Pharmaceuticals Company Details
11.7.2 HemaQuest Pharmaceuticals Business Overview
11.7.3 HemaQuest Pharmaceuticals Hemoglobinopathy Treatment Introduction
11.7.4 HemaQuest Pharmaceuticals Revenue in Hemoglobinopathy Treatment Business (2016-2021)
11.7.5 HemaQuest Pharmaceuticals Recent Development
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Company Details
11.8.2 Eli Lilly and Company Business Overview
11.8.3 Eli Lilly and Company Hemoglobinopathy Treatment Introduction
11.8.4 Eli Lilly and Company Revenue in Hemoglobinopathy Treatment Business (2016-2021)
11.8.5 Eli Lilly and Company Recent Development
11.9 Celgene
11.9.1 Celgene Company Details
11.9.2 Celgene Business Overview
11.9.3 Celgene Hemoglobinopathy Treatment Introduction
11.9.4 Celgene Revenue in Hemoglobinopathy Treatment Business (2016-2021)
11.9.5 Celgene Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hemoglobinopathy Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Hydroxyurea
Table 3. Key Players of Glutamine
Table 4. Key Players of Zynteglo
Table 5. Key Players of Other
Table 6. Global Hemoglobinopathy Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Hemoglobinopathy Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Hemoglobinopathy Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Hemoglobinopathy Treatment Market Share by Regions (2016-2021)
Table 10. Global Hemoglobinopathy Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Hemoglobinopathy Treatment Market Share by Regions (2022-2027)
Table 12. Hemoglobinopathy Treatment Market Trends
Table 13. Hemoglobinopathy Treatment Market Drivers
Table 14. Hemoglobinopathy Treatment Market Challenges
Table 15. Hemoglobinopathy Treatment Market Restraints
Table 16. Global Hemoglobinopathy Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Hemoglobinopathy Treatment Market Share by Players (2016-2021)
Table 18. Global Top Hemoglobinopathy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemoglobinopathy Treatment as of 2020)
Table 19. Ranking of Global Top Hemoglobinopathy Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Hemoglobinopathy Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Hemoglobinopathy Treatment Product Solution and Service
Table 23. Date of Enter into Hemoglobinopathy Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Hemoglobinopathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Hemoglobinopathy Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Hemoglobinopathy Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Hemoglobinopathy Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Hemoglobinopathy Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Hemoglobinopathy Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Hemoglobinopathy Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Hemoglobinopathy Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Hemoglobinopathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Hemoglobinopathy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Hemoglobinopathy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Hemoglobinopathy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Hemoglobinopathy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Hemoglobinopathy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Hemoglobinopathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Hemoglobinopathy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Hemoglobinopathy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Hemoglobinopathy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Hemoglobinopathy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Hemoglobinopathy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Hemoglobinopathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Hemoglobinopathy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Hemoglobinopathy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Hemoglobinopathy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Hemoglobinopathy Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Hemoglobinopathy Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Hemoglobinopathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Hemoglobinopathy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Hemoglobinopathy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Hemoglobinopathy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Hemoglobinopathy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Hemoglobinopathy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Hemoglobinopathy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Hemoglobinopathy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Hemoglobinopathy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Hemoglobinopathy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Hemoglobinopathy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Hemoglobinopathy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Novartis Company Details
Table 64. Novartis Business Overview
Table 65. Novartis Hemoglobinopathy Treatment Product
Table 66. Novartis Revenue in Hemoglobinopathy Treatment Business (2016-2021) & (US$ Million)
Table 67. Novartis Recent Development
Table 68. AstraZeneca Company Details
Table 69. AstraZeneca Business Overview
Table 70. AstraZeneca Hemoglobinopathy Treatment Product
Table 71. AstraZeneca Revenue in Hemoglobinopathy Treatment Business (2016-2021) & (US$ Million)
Table 72. AstraZeneca Recent Development
Table 73. Bluebird Company Details
Table 74. Bluebird Business Overview
Table 75. Bluebird Hemoglobinopathy Treatment Product
Table 76. Bluebird Revenue in Hemoglobinopathy Treatment Business (2016-2021) & (US$ Million)
Table 77. Bluebird Recent Development
Table 78. Bristol-Myers Squibb Company Details
Table 79. Bristol-Myers Squibb Business Overview
Table 80. Bristol-Myers Squibb Hemoglobinopathy Treatment Product
Table 81. Bristol-Myers Squibb Revenue in Hemoglobinopathy Treatment Business (2016-2021) & (US$ Million)
Table 82. Bristol-Myers Squibb Recent Development
Table 83. Emmaus Medical Company Details
Table 84. Emmaus Medical Business Overview
Table 85. Emmaus Medical Hemoglobinopathy Treatment Product
Table 86. Emmaus Medical Revenue in Hemoglobinopathy Treatment Business (2016-2021) & (US$ Million)
Table 87. Emmaus Medical Recent Development
Table 88. Acceleron Pharma Company Details
Table 89. Acceleron Pharma Business Overview
Table 90. Acceleron Pharma Hemoglobinopathy Treatment Product
Table 91. Acceleron Pharma Revenue in Hemoglobinopathy Treatment Business (2016-2021) & (US$ Million)
Table 92. Acceleron Pharma Recent Development
Table 93. HemaQuest Pharmaceuticals Company Details
Table 94. HemaQuest Pharmaceuticals Business Overview
Table 95. HemaQuest Pharmaceuticals Hemoglobinopathy Treatment Product
Table 96. HemaQuest Pharmaceuticals Revenue in Hemoglobinopathy Treatment Business (2016-2021) & (US$ Million)
Table 97. HemaQuest Pharmaceuticals Recent Development
Table 98. Eli Lilly and Company Company Details
Table 99. Eli Lilly and Company Business Overview
Table 100. Eli Lilly and Company Revenue in Hemoglobinopathy Treatment Business (2016-2021) & (US$ Million)
Table 101. Eli Lilly and Company Recent Development
Table 102. Celgene Company Details
Table 103. Celgene Business Overview
Table 104. Celgene Hemoglobinopathy Treatment Product
Table 105. Celgene Revenue in Hemoglobinopathy Treatment Business (2016-2021) & (US$ Million)
Table 106. Celgene Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hemoglobinopathy Treatment Market Share by Type: 2020 VS 2027
Figure 2. Hydroxyurea Features
Figure 3. Glutamine Features
Figure 4. Zynteglo Features
Figure 5. Other Features
Figure 6. Global Hemoglobinopathy Treatment Market Share by Application: 2020 VS 2027
Figure 7. Sickle Cell Diseases Case Studies
Figure 8. Thalassemia Case Studies
Figure 9. Hemoglobinopathy Treatment Report Years Considered
Figure 10. Global Hemoglobinopathy Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Hemoglobinopathy Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Hemoglobinopathy Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Hemoglobinopathy Treatment Market Share by Regions (2022-2027)
Figure 14. Global Hemoglobinopathy Treatment Market Share by Players in 2020
Figure 15. Global Top Hemoglobinopathy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemoglobinopathy Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Hemoglobinopathy Treatment Revenue in 2020
Figure 17. Global Hemoglobinopathy Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Hemoglobinopathy Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Hemoglobinopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Hemoglobinopathy Treatment Market Share by Type (2016-2027)
Figure 21. North America Hemoglobinopathy Treatment Market Share by Application (2016-2027)
Figure 22. North America Hemoglobinopathy Treatment Market Share by Country (2016-2027)
Figure 23. United States Hemoglobinopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Hemoglobinopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Hemoglobinopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Hemoglobinopathy Treatment Market Share by Type (2016-2027)
Figure 27. Europe Hemoglobinopathy Treatment Market Share by Application (2016-2027)
Figure 28. Europe Hemoglobinopathy Treatment Market Share by Country (2016-2027)
Figure 29. Germany Hemoglobinopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Hemoglobinopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Hemoglobinopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Hemoglobinopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Hemoglobinopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Hemoglobinopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Hemoglobinopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Hemoglobinopathy Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Hemoglobinopathy Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Hemoglobinopathy Treatment Market Share by Region (2016-2027)
Figure 39. China Hemoglobinopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Hemoglobinopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Hemoglobinopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Hemoglobinopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Hemoglobinopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Hemoglobinopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Hemoglobinopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Hemoglobinopathy Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Hemoglobinopathy Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Hemoglobinopathy Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Hemoglobinopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Hemoglobinopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Hemoglobinopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Hemoglobinopathy Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Hemoglobinopathy Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Hemoglobinopathy Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Hemoglobinopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Hemoglobinopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Hemoglobinopathy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Novartis Revenue Growth Rate in Hemoglobinopathy Treatment Business (2016-2021)
Figure 59. AstraZeneca Revenue Growth Rate in Hemoglobinopathy Treatment Business (2016-2021)
Figure 60. Bluebird Revenue Growth Rate in Hemoglobinopathy Treatment Business (2016-2021)
Figure 61. Bristol-Myers Squibb Revenue Growth Rate in Hemoglobinopathy Treatment Business (2016-2021)
Figure 62. Emmaus Medical Revenue Growth Rate in Hemoglobinopathy Treatment Business (2016-2021)
Figure 63. Acceleron Pharma Revenue Growth Rate in Hemoglobinopathy Treatment Business (2016-2021)
Figure 64. HemaQuest Pharmaceuticals Revenue Growth Rate in Hemoglobinopathy Treatment Business (2016-2021)
Figure 65. Eli Lilly and Company Revenue Growth Rate in Hemoglobinopathy Treatment Business (2016-2021)
Figure 66. Celgene Revenue Growth Rate in Hemoglobinopathy Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

以下、関連資料のご紹介

世界のヘモグロビン症用治療薬市場規模・現状・予測（2021年-2027年）

Global Hemoglobinopathy Treatment Drug Market Size, Status and Forecast 2021-2027
QFJ1-4298 2021年6月 117Pages
QYResearch社発行の本調査レポートでは、ヘモグロビン症用治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（鎮痛剤、抗生物質、ACE阻害剤、ヒドロキシウレア、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規...

世界のヘモグロビン症治療薬市場規模・現状・予測（2021年-2027年）

Global Hemoglobinopathy Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5773 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、ヘモグロビン症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヒドロキシウレア、グルタミン、ジンテグロ、その他）、用途別市場規模（鎌状赤血球症、サラセミア）、主要地域別市場規模（北米、アメリカ、...

世界の成人用ヘモグロビン症検査市場規模・現状・予測（2021年-2027年）

Global Adult Hemoglobinopathy Testing Market Size, Status and Forecast 2021-2027
QFJ1-5066 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、成人用ヘモグロビン症検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（HPLC検出、Hb電気泳動、質量分析、その他）、用途別市場規模（病院、医科大学、その他）、主要地域別市場規模（北米、アメリカ、欧...

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の天然痘治療市場規模・現状・予測（2021年-2027年）

Global Smallpox Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6015 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、天然痘治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、ワクチン）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の総胆管結石症治療市場規模・現状・予測（2021年-2027年）

Global Choledocholithiasis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4004 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、総胆管結石症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科的治療）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界のウィルムス腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Wilms' Tumor Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6071 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ウィルムス腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カボザンチニブ、SEL-12034、ラコツモマブ、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメ...

世界の色汗症治療市場規模・現状・予測（2021年-2027年）

Global Chromhidrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5658 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、色汗症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アポクリン色汗症、エクリン色汗症、偽色汗症）、用途別市場規模（病院＆診療所、専門医＆皮膚科医院、その他）、主要地域別市場規模（北米、アメリカ、...

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の痙性斜頸治療市場規模・現状・予測（2021年-2027年）

Global Cervical Dystonia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5653 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、痙性斜頸治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ボツリヌス菌、抗コリン作用薬、ドーパミン作動薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（...

世界のヘモグロビン症治療薬市場規模・現状・予測（2021年-2027年） Hemoglobinopathy includes a range of disorders, which occur due to altered structure of hemoglobin. Market Analysis and Insights: Global Hemoglobinopathy Drugs Market The global Hemoglobinopathy Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR o…
世界のヘモグロビン症用治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hemoglobinopathy Treatment Drug Market The global Hemoglobinopathy Treatment Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data i…
世界の成人用ヘモグロビン症検査市場規模・現状・予測（2021年-2027年） The Adult Hemoglobinosis Test is a set of tests used to determine the presence and relative amount of abnormal forms of hemoglobin to screen or diagnose hemoglobinopathies and to adults. Market Analysis and Insights: Global Adult Hemoglobinopathy Testing Market The global Adult Hemoglobinopathy Test…
世界のαサラセミア治療市場規模・現状・予測（2021年-2027年） Alpha thalassemia causes due to deficiency or absence of alpha globin chains results in alpha thalassemia which is asymptomatic with general hematologic findings and gains silent carrier status. Market Analysis and Insights: Global Alpha Thalassemia Treatment Market The global Alpha Thalassemia Tre…
世界のアルコール性肝疾患治療市場規模・現状・予測（2021年-2027年） Alcoholic liver diseases are the result of overconsumption of alcohol, which damages the liver, leading to liver cirrhosis, inflammation, and liver scarring. Market Analysis and Insights: Global Alcoholic Liver Diseases Treatment Market The global Alcoholic Liver Diseases Treatment market size is p…